WebJul 28, 2024 · Bristol Myers expects full-year revenue to grow by a high single-digit percentage and for adjusted profit to come in at $7.35-$7.55 per share. BMY stock analysts called for $7.45 earnings per ... WebFeb 4, 2024 · The company reported non-GAAP net earnings attributable to Bristol Myers Squibb of $3.3 billion, or $1.46 per share, in the fourth quarter, compared to non-GAAP net earnings of $2.4 billion, or $1.22 per share, for the same period a year ago. ... Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, …
Bookmaker 888 sees higher 2024 profit, partial Mideast revenue …
WebFeb 4, 2024 · Bristol Myers Squibb posted fourth quarter revenues of $12.0 billion, an increase of 8%, driven by Eliquis, our Immuno-Oncology and new product portfolios. U.S. … WebJul 28, 2024 · Bristol-Myers Squibb Company BMY reported better-than-expected results for the second quarter of 2024 as blockbuster immuno-oncology drug, Opdivo, returned to … gas exchange site
Bristol-Myers Squibb (BMY) - Revenue
Web1 hour ago · FY23 Outlook: D-Wave expects revenue of $12 million - $13 million representing year-over-year growth of 67% to 80%. The company expects to maintain its … WebOn Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q4 2024 earnings per share (EPS) of $0.96, up 10.28% year over year. Total Bristol Myers Squibb Co earnings for the quarter were $2.02 billion. In the same quarter last year, Bristol Myers Squibb Co's earnings per share (EPS) was $1.07. WebApr 14, 2024 · REUTERS/Eva Plevier/File Photo. April 14 (Reuters) - Dutch navigation and digital mapping company TomTom (TOM2.AS) on Friday reported better-than-expected … david badawi md arlington heights il